E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore to Participate at Upcoming Investor Conferences
September 23, 2021 08:00 ET | electroCore, Inc.
ROCKAWAY, NJ, Sept. 23, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Begins Enrolling Subjects for Phase 1 Clinical Trial to Treat Concussion
September 22, 2021 08:39 ET | Odyssey Group International
IRVINE, CA, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a medical company focused on developing unique, life-saving medical...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore Announces Peter Cuneo as Board Chairman 
September 20, 2021 08:00 ET | electroCore, Inc.
ROCKAWAY, NJ, Sept. 20, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the Board of Directors has appointed Peter...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore Announces New Patent Expanding Claims Related to Delivery of Non-Invasive Vagus Nerve Stimulation Therapy Using Mobile Devices
September 15, 2021 08:00 ET | electroCore, Inc.
ROCKAWAY, NJ, Sept. 15, 2021 (GLOBE NEWSWIRE) --  electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the United States Patent and Trademark...
logo-brainhq-hi-res-hori.png
Study: Brain Training Can Address Persistent Issues from Traumatic Brain Injuries
September 14, 2021 08:00 ET | Posit Science
SAN FRANCISCO, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Researchers at New York University published a study among patients with cognitive deficits from Traumatic Brain Injuries showing that...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore Announces 510(k) Clearance of gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) to Treat Paroxysmal Hemicrania and Hemicrania Continua
September 14, 2021 08:00 ET | electroCore, Inc.
ROCKAWAY, NJ, Sept. 14, 2021 (GLOBE NEWSWIRE) --  electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that on September 10, 2021 the company...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International to Present at the HC Wainwright 23rd Annual Global Investment Conference
September 09, 2021 08:00 ET | Odyssey Group International
IRVINE, CA, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC: ODYY) (the "Company" or "Odyssey"), a health related company focused on developing unique, medical products...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Approved to Start Human Trial to Treat Concussion        
September 01, 2021 08:30 ET | Odyssey Group International
IRVINE, CA, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a company focused on developing unique, life-saving medical products, today...
Protecting workers from TBI-causing brain shear the aim of partnership between Ergodyne and global helmet safety experts at Mips
August 31, 2021 11:01 ET | Ergodyne
St. Paul, Minn, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Ergodyne announced a major partnership with Mips to integrate the highly innovative Mips® Elevate safety system into Skullerz® Safety Helmets. ...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore to Present at the HC Wainwright 23rd Annual Global Investment Conference 
August 31, 2021 08:00 ET | electroCore, Inc.
ROCKAWAY, NJ, Aug. 31, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will...